Suzanne N. Morin

Profile picture of Suzanne Morin

Suzanne N. Morin, MD MSc FRCP FACP

Associate Professor, Department of Medicine
Associate Member, Division of Endocrinology
Director, Division of General Internal Medicine, McGill University Health Centre
Montreal General Hospital, 1650 Cedar Avenue, Room B2.118, Montreal, QC H3G 1A4

Tel: 514-934-8054

suzanne.morin [at]

Biographical Sketch

Dr Suzanne Morin graduated from the Faculty of Medicine at Université Laval de Québec, did her Internal Medicine specialty training and obtained a Master’s in epidemiology and biostatistics from McGill University, where she is now Associate Professor in the Department of Medicine, Director of the division of General Internal Medicine, member of the Endocrinology and Clinical Epidemiology Divisions and scientist at the Centre for Outcomes Research and Evaluation of the Research Institute of the McGill University Health Center.

She is a scholar from the Fonds de Recherche du Québec en Santé, and has received funding from the Canadian Institutes of Health Research (CIHR) and other peer-reviewed agencies. She is past Chair of Osteoporosis Canada Scientific Advisory Council and a member of the CIHR Institute of Musculoskeletal Health and Arthritis Advisory Committee.


Osteoporosis, fractures, bone mineral density, atypical femur fractures, rehabilitation, digital health, clinical practice guidelines

Research or Clinical Activities

Dr Morin’s research program focuses on the evaluation of outcomes of osteoporosis and its treatment through the conduct of clinical trials, analysis of large healthcare administrative datasets and of large cohorts, and implementation of initiatives for patients who have sustained fractures such as secondary fracture prevention, pain management and functional recovery, with an interest in wearables and mobile applications. She studies the pathogenesis of bisphosphonate-associated atypical femur fractures and has initiated and lead the Quebec AFF Registry. She is a leader in clinical practice guidelines development for the management and prevention of osteoporosis and fractures.

Selected Recent Publications

1. Morin SN, Lix LM, Leslie WD et al. Long-term risk of subsequent major osteoporosis fracture and hip fracture in men and women: a population-based observational study with a 25-year follow-up. Osteoporosis International 2021, June 24; PMID: 34165587

2. Farlay D, Rizzo S, Morin SN, Boivin G et al. Duration-Dependent Increase of Human Bone Matrix Mineralization in Long-term Bisphosphonate Users with Atypical Femur Fractures. J Bone Miner Res. 2021 2021 36 (6): 1031-1041; PMID: 33434290

3. Morin SN, Rahme E, Goltzman D et al. Differences in fracture prevalence and in bone mineral density between Chinese and White Canadians: the Canadian Multicentre Osteoporosis Study (CaMos). Arch Osteoporos. 2020 Sep 21;15(1):147; PMID: 32955674.

4. Morin SN, Leslie WD et al. Patient engagement in clinical guidelines development: input from > 1000 members of the Canadian Osteoporosis Patient Network. Osteoporos Int. 2020 31 (5): 867-874; PMID: 31838552, PMCID: PMC7170816

PubMed Publications – S. Morin


Back to top